Drug-induced epigenomic plasticity reprograms circadian rhythm regulation to drive prostate cancer towards androgen-independence.
Cancer Discov. 2022 Jun 27:candisc.0576.2021-5-3 12:14:47.513. doi: 10.1158/2159-8290.CD-21-0576. Online ahead of print.
Cancer Discov. 2022.
PMID: 35754340